Self-disseminating vaccines for emerging infectious diseases
| dc.contributor.author | Murphy, Aisling | |
| dc.contributor.author | Redwood, AJ | |
| dc.contributor.author | Jarvis, Michael A | |
| dc.date.accessioned | 2016-04-04T13:50:41Z | |
| dc.date.available | 2016-04-04T13:50:41Z | |
| dc.date.issued | 2016-01-02 | |
| dc.identifier.issn | 1476-0584 | |
| dc.identifier.issn | 1744-8395 | |
| dc.identifier.uri | http://hdl.handle.net/10026.1/4470 | |
| dc.description.abstract |
Modern human activity fueled by economic development is profoundly altering our relationship with microorganisms. This altered interaction with microbes is believed to be the major driving force behind the increased rate of emerging infectious diseases from animals. The spate of recent infectious disease outbreaks, including Ebola virus disease and Middle East respiratory syndrome, emphasize the need for development of new innovative tools to manage these emerging diseases. Disseminating vaccines are one such novel approach to potentially interrupt animal to human (zoonotic) transmission of these pathogens. | |
| dc.format.extent | 31-39 | |
| dc.format.medium | Print-Electronic | |
| dc.language | en | |
| dc.language.iso | eng | |
| dc.publisher | Informa UK Limited | |
| dc.subject | Disseminating | |
| dc.subject | Ebola | |
| dc.subject | emerging infectious disease | |
| dc.subject | zoonosis | |
| dc.subject | cytomegalovirus | |
| dc.subject | wildlife | |
| dc.subject | epidemic | |
| dc.subject | transmission | |
| dc.subject | vaccine | |
| dc.subject | CMV | |
| dc.title | Self-disseminating vaccines for emerging infectious diseases | |
| dc.type | journal-article | |
| dc.type | Journal Article | |
| dc.type | Research Support, Non-U.S. Gov't | |
| dc.type | Review | |
| plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000366198800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
| plymouth.issue | 1 | |
| plymouth.volume | 15 | |
| plymouth.publication-status | Published | |
| plymouth.journal | Expert Review of Vaccines | |
| dc.identifier.doi | 10.1586/14760584.2016.1106942 | |
| plymouth.organisational-group | /Plymouth | |
| plymouth.organisational-group | /Plymouth/Faculty of Health | |
| plymouth.organisational-group | /Plymouth/Faculty of Health/School of Biomedical Sciences | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
| plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
| plymouth.organisational-group | /Plymouth/Research Groups | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
| plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
| plymouth.organisational-group | /Plymouth/Users by role | |
| plymouth.organisational-group | /Plymouth/Users by role/Academics | |
| dc.publisher.place | England | |
| dc.identifier.eissn | 1744-8395 | |
| dc.rights.embargoperiod | No embargo | |
| rioxxterms.versionofrecord | 10.1586/14760584.2016.1106942 | |
| rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.type | Journal Article/Review |
